Text Size

Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model

Liang H., Baudouin C., Daull P., Garrigue J.-S., Brignole-Baudouin F.


  • 2012
  • Molecular Vision
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Pharmacology

  • Categories

    Preclinical development

  • Affiliations

    INSERM, Paris, France; UPMC Univ Paris 06, Institut de la Vision, Paris, France; CNRS, Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France; Assistance Publique - Hôpitaux de Paris Hôpital Ambroise Paré, Service d'Ophtalmologie, Boulogne-Billancourt, France; Université Versailles Saint-Quentin-en-Yvelines, Versailles, France; Novagali Pharma, Evry, France; Université Paris Descartes, Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Laboratoire de Toxicologie, Paris, France

Related Publications

Characterization of monocarboxylate uptake and immunohistochemical demonstration of monocarboxylate transporters in cultured rabbit corneal epithelial cells

Kawazu K., Fujii S., Yamada K., Shinomiya K., Katsuta O., Horibe Y.


Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models

Dota A., Takaoka-Shichijo Y., Nakamura M.


Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases

Kato M., Hagiwara Y., Oda T., Imamura-Takai M., Aono H., Nakamura M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022